8-KThe WireRoutine
Shareholder Vote
Filed Jun 9, 2023 · 3y ago · Accession 0001193125-23-164444
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Spyre Therapeutics, Inc.
- Ticker
- SYRE
- CIK
- 1636282
- Form type
- 8-K
- Filing date
- Jun 9, 2023
- Report date
- Jun 6, 2023
- Document
- d492050d8k.htm
- Size
- 159 KB